• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定阿尔茨海默病进展中的相关结果;患者和护理伙伴想了解哪些关于预后的信息?

Identifying relevant outcomes in the progression of Alzheimer's disease; what do patients and care partners want to know about prognosis?

作者信息

Mank Arenda, van Maurik Ingrid S, Bakker Els D, van de Glind Esther M M, Jönsson Linus, Kramberger Milica G, Novak Petr, Diaz Ana, Gove Dianne, Scheltens Philip, van der Flier Wiesje M, Visser Leonie N C

机构信息

Alzheimer Center Amsterdam Department of Neurology VU University Medical Center Amsterdam UMC Amsterdam the Netherlands.

Department of Epidemiology and Data Science Amsterdam UMC, Vrije Universiteit Amsterdam Amsterdam the Netherlands.

出版信息

Alzheimers Dement (N Y). 2021 Aug 20;7(1):e12189. doi: 10.1002/trc2.12189. eCollection 2021.

DOI:10.1002/trc2.12189
PMID:34458555
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8377775/
Abstract

BACKGROUND

Prognostic studies in the context of Alzheimer's disease (AD) mainly predicted time to dementia. However, it is questionable whether onset of dementia is the most relevant outcome along the AD disease trajectory from the perspective of patients and their care partners. Therefore, we aimed to identify the most relevant outcomes from the viewpoint of patients and care partners.

METHODS

We used a two-step, mixed-methods approach. As a first step we conducted four focus groups in the Netherlands to elicit a comprehensive list of outcomes considered important by patients ( = 12) and care partners ( = 14) in the prognosis of AD. The focus groups resulted in a list of 59 items, divided into five categories. Next, in an online European survey, we asked participants ( = 232; 99 patients, 133 care partners) to rate the importance of all 59 items (5-point Likert scale). As participants were likely to rate a large number of outcomes as "important" (4) or "very important" (5), we subsequently asked them to select the three items they considered most important.

RESULTS

The top-10 lists of items most frequently mentioned as "most important" by patients and care partners were merged into one core outcome list, comprising 13 items. Both patients and care partners selected outcomes from the category "cognition" most often, followed by items in the categories "functioning and dependency" and "physical health." No items from the category "behavior and neuropsychiatry" and "social environment" ended up in our core list of relevant outcomes.

CONCLUSION

We identified a core list of outcomes relevant to patients and care partner, and found that prognostic information related to cognitive decline, dependency, and physical health are considered most relevant by both patients and their care partners.

摘要

背景

阿尔茨海默病(AD)背景下的预后研究主要预测痴呆发生时间。然而,从患者及其护理伙伴的角度来看,痴呆的发生是否是AD疾病轨迹中最相关的结局尚存在疑问。因此,我们旨在从患者和护理伙伴的角度确定最相关的结局。

方法

我们采用了两步混合方法。第一步,我们在荷兰进行了四个焦点小组讨论,以得出患者(n = 12)和护理伙伴(n = 14)认为在AD预后中重要的全面结局清单。焦点小组讨论得出了一份包含59项内容的清单,分为五类。接下来,在一项欧洲在线调查中,我们要求参与者(n = 232;99名患者,133名护理伙伴)对所有59项内容的重要性进行评分(5点李克特量表)。由于参与者可能会将大量结局评为“重要”(4)或“非常重要”(5),随后我们要求他们选择三项他们认为最重要的内容。

结果

患者和护理伙伴最常提及为“最重要”的前10项内容合并为一个核心结局清单,包括13项。患者和护理伙伴最常从“认知”类别中选择结局,其次是“功能与依赖”和“身体健康”类别中的内容。“行为与神经精神学”和“社会环境”类别中的内容均未进入我们的相关核心结局清单。

结论

我们确定了一份与患者和护理伙伴相关的核心结局清单,并发现与认知能力下降、依赖和身体健康相关的预后信息被患者及其护理伙伴认为最相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67cf/8377775/7a5a792966a8/TRC2-7-e12189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67cf/8377775/7a5a792966a8/TRC2-7-e12189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67cf/8377775/7a5a792966a8/TRC2-7-e12189-g001.jpg

相似文献

1
Identifying relevant outcomes in the progression of Alzheimer's disease; what do patients and care partners want to know about prognosis?确定阿尔茨海默病进展中的相关结果;患者和护理伙伴想了解哪些关于预后的信息?
Alzheimers Dement (N Y). 2021 Aug 20;7(1):e12189. doi: 10.1002/trc2.12189. eCollection 2021.
2
Medical Journey of Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease Dementia: A Cross-sectional Survey of Patients, Care Partners, and Neurologists.轻度认知障碍和轻度阿尔茨海默病性痴呆患者的就医历程:一项针对患者、护理伙伴和神经科医生的横断面调查
J Prev Alzheimers Dis. 2023;10(2):162-170. doi: 10.14283/jpad.2023.21.
3
Perspectives of patients, care partners, and primary care physicians on management of mild cognitive impairment and mild Alzheimer's disease dementia.患者、护理伙伴和初级保健医生对轻度认知障碍和轻度阿尔茨海默病痴呆症管理的看法。
Postgrad Med. 2023 Jun;135(5):530-538. doi: 10.1080/00325481.2023.2217025. Epub 2023 May 29.
4
Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.以目标为导向的认知康复治疗早期阿尔茨海默病及相关痴呆: GREAT RCT 研究。
Health Technol Assess. 2019 Mar;23(10):1-242. doi: 10.3310/hta23100.
5
Assessing what matters most to patients with or at risk for Alzheimer's and care partners: a qualitative study evaluating symptoms, impacts, and outcomes.评估患有或有阿尔茨海默病风险的患者及其护理伙伴最关心的问题:一项评估症状、影响和结果的定性研究。
Alzheimers Res Ther. 2020 Jul 30;12(1):90. doi: 10.1186/s13195-020-00659-6.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
What is important to people living with dementia?: the 'long-list' of outcome items in the development of a core outcome set for use in the evaluation of non-pharmacological community-based health and social care interventions.对患有痴呆症的人来说重要的是什么?:在开发用于评估非药物性基于社区的健康和社会护理干预措施的核心结局集的过程中,“长列表”结局指标。
BMC Geriatr. 2019 Mar 27;19(1):94. doi: 10.1186/s12877-019-1103-5.
8
9
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
10
Assessing What Matters to People Affected by Alzheimer's Disease: A Quantitative Analysis.评估对阿尔茨海默病患者重要的事项:一项定量分析。
Neurol Ther. 2023 Apr;12(2):505-527. doi: 10.1007/s40120-023-00445-0. Epub 2023 Feb 10.

引用本文的文献

1
Exploring mutation carriers' preferences regarding onset and progression of disease predictions for adult-onset genetic neurodegenerative diseases: a qualitative interview study.探索成年发病型遗传性神经退行性疾病突变携带者对疾病预测的发病和进展的偏好:一项定性访谈研究。
Hum Genet. 2025 May 26. doi: 10.1007/s00439-025-02750-0.
2
Anticipating the Future in an Uncertain Present: How Individuals Living With Medically Unexplained Cognitive Complaints Value Biomarker-Based Prognostics.在不确定的当下展望未来:患有医学上无法解释的认知主诉的个体如何看待基于生物标志物的预后。
Health Expect. 2025 Jun;28(3):e70284. doi: 10.1111/hex.70284.
3

本文引用的文献

1
Assessing what matters most to patients with or at risk for Alzheimer's and care partners: a qualitative study evaluating symptoms, impacts, and outcomes.评估患有或有阿尔茨海默病风险的患者及其护理伙伴最关心的问题:一项评估症状、影响和结果的定性研究。
Alzheimers Res Ther. 2020 Jul 30;12(1):90. doi: 10.1186/s13195-020-00659-6.
2
Communicating uncertainties when disclosing diagnostic test results for (Alzheimer's) dementia in the memory clinic: The ABIDE project.在记忆诊所中披露(阿尔茨海默病)痴呆诊断测试结果时的不确定性沟通:ABIDE 项目。
Health Expect. 2020 Feb;23(1):52-62. doi: 10.1111/hex.12964. Epub 2019 Oct 22.
3
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study.
How do we put meaning into meaningful benefit? Perspectives from the lived experience.
我们如何将意义赋予有意义的益处?来自生活体验的视角。
Alzheimers Dement (N Y). 2025 May 14;11(2):e70095. doi: 10.1002/trc2.70095. eCollection 2025 Apr-Jun.
4
A scoping review of remote and unsupervised digital cognitive assessments in preclinical Alzheimer's disease.对临床前阿尔茨海默病远程和无监督数字认知评估的范围综述。
NPJ Digit Med. 2025 May 10;8(1):266. doi: 10.1038/s41746-025-01583-5.
5
Measuring time saved in Alzheimer's disease: What is a meaningful slowing of progression?衡量阿尔茨海默病中节省的时间:有意义的疾病进展减缓是怎样的?
Alzheimers Dement (N Y). 2025 Apr 11;11(2):e70081. doi: 10.1002/trc2.70081. eCollection 2025 Apr-Jun.
6
Time to nursing home admission and death in people with dementia: systematic review and meta-analysis.痴呆症患者入住养老院及死亡的时间:系统评价与荟萃分析。
BMJ. 2025 Jan 8;388:e080636. doi: 10.1136/bmj-2024-080636.
7
Defining benefit: Clinically and biologically meaningful outcomes in the next-generation Alzheimer's disease clinical care pathway.定义获益:下一代阿尔茨海默病临床护理路径中具有临床和生物学意义的结果。
Alzheimers Dement. 2025 Feb;21(2):e14425. doi: 10.1002/alz.14425. Epub 2024 Dec 19.
8
A scoping review of remote and unsupervised digital cognitive assessments in preclinical Alzheimer's disease.临床前阿尔茨海默病远程和非监督式数字认知评估的范围综述
medRxiv. 2025 Mar 25:2024.09.25.24314349. doi: 10.1101/2024.09.25.24314349.
9
Predicting Cognitive Decline in Amyloid-Positive Patients With Mild Cognitive Impairment or Mild Dementia.预测伴有轻度认知障碍或轻度痴呆的淀粉样蛋白阳性患者的认知能力下降。
Neurology. 2024 Aug 13;103(3):e209605. doi: 10.1212/WNL.0000000000209605. Epub 2024 Jul 10.
10
Precision medicine in neurodegeneration: the IHI-PROMINENT project.神经退行性疾病的精准医学:IHI-PROMINENT项目
Front Neurol. 2023 Aug 2;14:1175922. doi: 10.3389/fneur.2023.1175922. eCollection 2023.
基于生物标志物的轻度认知障碍患者预后预测(ABIDE):一项建模研究。
Lancet Neurol. 2019 Nov;18(11):1034-1044. doi: 10.1016/S1474-4422(19)30283-2. Epub 2019 Sep 13.
4
What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic review.对于轻度认知障碍或阿尔茨海默病患者、他们的照护者以及医疗保健专业人员而言,哪些结果至关重要?一项系统综述。
Alzheimers Dement (Amst). 2019 Mar 7;11:231-247. doi: 10.1016/j.dadm.2018.12.003. eCollection 2019 Dec.
5
Clinicians' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE project.临床医生对阿尔茨海默病诊断测试中对话及共同决策的看法:ABIDE项目
Alzheimers Dement (N Y). 2017 May 10;3(3):305-313. doi: 10.1016/j.trci.2017.03.009. eCollection 2017 Sep.
6
Diagnostic dilemmas in Alzheimer's disease: Room for shared decision making.阿尔茨海默病的诊断困境:共同决策的空间
Alzheimers Dement (N Y). 2017 May 9;3(3):301-304. doi: 10.1016/j.trci.2017.03.008. eCollection 2017 Sep.
7
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.路易体痴呆的诊断与管理:DLB联盟第四次共识报告
Neurology. 2017 Jul 4;89(1):88-100. doi: 10.1212/WNL.0000000000004058. Epub 2017 Jun 7.
8
Priority of Treatment Outcomes for Caregivers and Patients with Mild Cognitive Impairment: Preliminary Analyses.轻度认知障碍患者及其照料者治疗结果的优先级:初步分析
Neurol Ther. 2016 Dec;5(2):183-192. doi: 10.1007/s40120-016-0049-1. Epub 2016 Aug 9.
9
Learning Biomarker Models for Progression Estimation of Alzheimer's Disease.学习用于阿尔茨海默病进展评估的生物标志物模型。
PLoS One. 2016 Apr 20;11(4):e0153040. doi: 10.1371/journal.pone.0153040. eCollection 2016.
10
Which medical and social decision topics are important after early diagnosis of Alzheimer's Disease from the perspectives of people with Alzheimer's Disease, spouses and professionals?从阿尔茨海默病患者、配偶及专业人士的角度来看,在阿尔茨海默病早期诊断之后,哪些医疗和社会决策主题是重要的?
BMC Res Notes. 2016 Mar 8;9:149. doi: 10.1186/s13104-016-1960-3.